Description

Listing of 939,930 equity shares of ASTAL LABORATORIES LIMITED issued on preferential basis pursuant to warrant conversion, effective October 8, 2025.

Summary

BSE has approved the listing of 939,930 equity shares of ASTAL LABORATORIES LIMITED (Scrip Code: 512600) issued to Non-Promoters on a preferential basis pursuant to warrant conversion. The shares are permitted to trade from October 8, 2025, with a lock-in period until April 30, 2026.

Key Points

  • 939,930 equity shares of Rs. 10/- each issued at a premium of Rs. 30/-
  • Issue price: Rs. 40/- per share
  • Issued to Non-Promoters on preferential basis pursuant to warrant conversion
  • Shares rank pari-passu with existing equity shares
  • Distinctive Numbers: 9856371 to 10796300
  • Date of Allotment: August 12, 2025
  • ISIN: INE307N01014

Regulatory Changes

No regulatory changes introduced by this circular.

Compliance Requirements

  • Trading members are informed of the new securities listing
  • All 939,930 shares subject to lock-in until April 30, 2026
  • Shares cannot be transferred or sold before the lock-in expiry date

Important Dates

  • Allotment Date: August 12, 2025
  • Trading Commencement: October 8, 2025 (Wednesday)
  • Lock-in Expiry: April 30, 2026

Impact Assessment

This is a routine preferential allotment listing with minimal market impact. The addition of 939,930 shares represents capital infusion through warrant conversion. The lock-in period until April 30, 2026 ensures these shares will not enter the market immediately, preventing short-term dilution effects. Trading members can facilitate transactions in these securities from October 8, 2025.

Impact Justification

Routine preferential allotment listing with limited market impact; affects specific non-promoter allottees with lock-in restrictions.